Eurazeo share falls 2.5% and drops below its 20-day moving average
Eurazeo share is among the notable declines of the SBF 120 on Tuesday, in a broadly downward-trending European market. The investment group, specializing in private equity on the European mid-market, sees its price eroding after several weeks of rebound, erasing part of the monthly gain accumulated in August.
A decline of 2.41% that places the security below its 20-day moving average
Eurazeo falls 2.41% during the session to return to €49.04, after closing the previous day at €50.25. This decline places the security among the strongest declines of the SBF 120, in a challenging market context: the CAC 40 falls 0.43% and the DAX 0.82% during the session. The short-term momentum has reversed, as the price drops below the 20-day MA at €51.21, with a gap of -4.24%. The configuration remains more nuanced over longer horizons: Eurazeo remains above its 50-day MA at €46.40 (gap +5.69%) and its 200-day MA at €47.54 (gap +3.16%), which reflects an underlying trend still preserved.
The RSI at 54, practically neutral, signals neither overbought nor oversold conditions, while the MACD, with a slightly negative histogram at -0.30, indicates a loss of momentum from the bullish drive of recent weeks. Over one week, the security falls 2.02%, but remains up 3.46% for the month and 5.46% over three months, which tempers the significance of today's correction. The identified support level at €43.70 remains distant, with resistance at €53.50 now constituting the next level to reach.
A solid August in the background, an Aroma-Zone disposal that outlines the strategy
Today's decline occurs in a fundamentally sound context. When publishing 2025 annual results on March 11, 2026, Eurazeo had posted record fundraising of €5.5 billion over the fiscal year and market share gains, confirming the strength of its model in the European mid-market segment. More recently, the negotiation for the disposal of Aroma-Zone to Partners Group, announced in early August, illustrates the asset rotation underway within the portfolio: Eurazeo would reinvest alongside the Swiss acquirer, maintaining exposure to the natural cosmetics brand it has supported since 2021.
The security's monthly volatility, at 8.54%, remains moderate for a listed private equity value, which puts the amplitude of Tuesday's move into perspective. The VIX rises nearly 10% during the session to 15.85, signaling a slight increase in market anxiety on equities, a contextual element to which financial values exposed to alternative assets remain historically sensitive. The zone between €46 and €47, corresponding to the two long-term moving averages, constitutes the technical floor to monitor should the correction extend further.
